<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Brainstorm Cell Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Chaim Lebovits
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Private Health Management, Inc.

    Private Health Management, Inc.

    Private Health Management was founded in 2007 after Leslie D. Michelson and Gregg ...

    Private Health Management was founded in 2007 a...

    Fundraising Status:    EC
    Filing Type:    CF
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    KemPharm, Inc.

    KemPharm, Inc.

    KemPharmÂŽ is a clinical-stage specialty pharmaceutical company engaged in the dis...

    KemPharmÂŽ is a clinical-stage specialty pharma...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    Axcella Health Inc.

    Axcella Health Inc.

    Axcella is designing and developing AXA Candidates, compositions of endogenous met...

    Axcella is designing and developing AXA Candida...

    Filing Type:    PU
    Solid Biosciences Inc.

    Solid Biosciences Inc.

    Solid Biosciences is a life science company focused solely on finding meaningful t...

    Solid Biosciences is a life science company foc...

    Filing Type:    PU
    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    Celyad SA

    Celyad SA

    Celyad is a biopharmaceutical company, specialized in CAR-T cell therapy, that is ...

    Celyad is a biopharmaceutical company, speciali...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    WindowMirror Inc

    WindowMirror Inc

    WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...

    WindowMirror's BUTTERFLY will be a collaborativ...

    Amount Raised:    $14,462.00
    Fundraising Status:    EC
    Filing Type:    CF
    Alterity Therapeutics Limited

    Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative di...

    We exist to create an alternate future for peop...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.